TrialThe Journal of clinical psychiatry2013

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

Cristina Cusin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.